BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

606 related articles for article (PubMed ID: 17760727)

  • 21. Duplicate breath testing to confirm eradication of Helicobacter pylori: incremental benefit and cost in 419 patients.
    Vakil N; Zullo A; Ricci C; Hassan C; Vaira D
    Aliment Pharmacol Ther; 2008 Dec; 28(11-12):1304-8. PubMed ID: 18774949
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Eradication therapy in Helicobacter pylori-positive patients with halitosis: long-term outcome.
    Katsinelos P; Tziomalos K; Chatzimavroudis G; Vasiliadis T; Katsinelos T; Pilpilidis I; Triantafillidis I; Paroutoglou G; Papaziogas B
    Med Princ Pract; 2007; 16(2):119-23. PubMed ID: 17303947
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Helicobacter pylori eradication: a randomized prospective study of triple therapy versus triple therapy plus lactoferrin and probiotics.
    de Bortoli N; Leonardi G; Ciancia E; Merlo A; Bellini M; Costa F; Mumolo MG; Ricchiuti A; Cristiani F; Santi S; Rossi M; Marchi S
    Am J Gastroenterol; 2007 May; 102(5):951-6. PubMed ID: 17313499
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Quadruple therapy with lactoferrin for Helicobacter pylori eradication: a randomised, multicentre study.
    Zullo A; De Francesco V; Scaccianoce G; Hassan C; Panarese A; Piglionica D; Panella C; Morini S; Ierardi E
    Dig Liver Dis; 2005 Jul; 37(7):496-500. PubMed ID: 15975536
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [The role of tetracycline in the retreatment after Helicobacter pylori eradication failure].
    Auriemma L; Signorelli S
    Minerva Med; 2001 Jun; 92(3):145-9. PubMed ID: 11404722
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lack of benefit of treating Helicobacter pylori infection in patients with functional dyspepsia. Randomized one-year follow-up study.
    Gisbert JP; Cruzado AI; Garcia-Gravalos R; Pajares JM
    Hepatogastroenterology; 2004; 51(55):303-8. PubMed ID: 15011890
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The efficacy of bismuth containing quadruple therapy as a first-line treatment option for Helicobacter pylori.
    Uygun A; Kadayifci A; Safali M; Ilgan S; Bagci S
    J Dig Dis; 2007 Nov; 8(4):211-5. PubMed ID: 17970879
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Oral health status and oral hygiene practices of patients with peptic ulcer and how these affect Helicobacter pylori eradication from the stomach.
    Namiot DB; Namiot Z; Kemona A; Bucki R; Gotebiewska M
    Helicobacter; 2007 Feb; 12(1):63-7. PubMed ID: 17241303
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Results of an open multicenter study of the efficiency of one-week anti-helicobacter therapy using omeprazole, clarithromycin, and amoxicillin in patients with duodenal peptic ulcer].
    Isakov VA; Maev IV; Simanenkov VI; Kononov AV; Abdulkhakov RA; Zakharova NV; Livzan MA; Predvechnaia IK
    Ter Arkh; 2003; 75(11):71-3. PubMed ID: 14708448
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of 7-day and 14-day proton pump inhibitor-containing triple therapy for Helicobacter pylori eradication: neither treatment duration provides acceptable eradication rate in Korea.
    Kim BG; Lee DH; Ye BD; Lee KH; Kim BW; Kim SG; Kim SW; Kim SK; Kim JJ; Kim HY; Park JJ; Park CY; Baik GH; Lee YC; Lee JH; Lee JH; Chun HJ; Hahm KB; Hong SJ; Lee SW; Jung HC
    Helicobacter; 2007 Feb; 12(1):31-5. PubMed ID: 17241298
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Influence of anti-ulcer drugs used in Japan on the result of (13)C-urea breath test for the diagnosis of Helicobacter pylori infection.
    Murakami K; Sato R; Okimoto T; Watanabe K; Nasu M; Fujioka T; Kodama M; Kagawa J
    J Gastroenterol; 2003; 38(10):937-41. PubMed ID: 14614600
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prevalence and treatment of Helicobacter pylori in patients with blepharitis.
    SaccĂ  SC; Pascotto A; Venturino GM; Prigione G; Mastromarino A; Baldi F; Bilardi C; Savarino V; Brusati C; Rebora A
    Invest Ophthalmol Vis Sci; 2006 Feb; 47(2):501-8. PubMed ID: 16431942
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efficacy of Helicobacter pylori eradication therapy in chronic liver disease.
    Jung SW; Lee SW; Hyun JJ; Kim DI; Koo JS; Yim HJ; Park JJ; Lee HS; Chun HJ; Um SH; Choi JH; Kim CD; Ryu HS
    Dig Liver Dis; 2009 Feb; 41(2):134-40. PubMed ID: 18436489
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Eradication of Helicobacter pylori does not reduce the incidence of gastroduodenal ulcers in patients on long-term NSAID treatment: double-blind, randomized, placebo-controlled trial.
    de Leest HT; Steen KS; Lems WF; Bijlsma JW; van de Laar MA; Huisman AM; Vonkeman HE; Houben HH; Kadir SW; Kostense PJ; van Tulder MW; Kuipers EJ; Boers M; Dijkmans BA
    Helicobacter; 2007 Oct; 12(5):477-85. PubMed ID: 17760715
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of Helicobacter pylori eradication on platelet recovery in patients with chronic idiopathic thrombocytopenic purpura.
    Sato R; Murakami K; Watanabe K; Okimoto T; Miyajima H; Ogata M; Ohtsuka E; Kodama M; Saburi Y; Fujioka T; Nasu M
    Arch Intern Med; 2004 Sep; 164(17):1904-7. PubMed ID: 15451766
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Healing of lymphocytic gastritis after Helicobacter pylori eradication therapy--a randomized, double-blind, placebo-controlled multicentre trial.
    Madisch A; Miehlke S; Neuber F; Morgner A; Kuhlisch E; Rappel S; Lehn N; Bayerdörffer E; Seitz G; Stolte M
    Aliment Pharmacol Ther; 2006 Feb; 23(4):473-9. PubMed ID: 16441467
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Eradication of Helicobacter pylori can facilitate immune reconstitution in HIV-1-infected immunological non-responders.
    Magen E; Elbirt D; Agmon-Levin N; Mishal J; Sthoeger Z
    Int J Infect Dis; 2010 Apr; 14(4):e322-7. PubMed ID: 19699671
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Efficacy and safety of Saccharomyces boulardii in the 14-day triple anti-Helicobacter pylori therapy: a prospective randomized placebo-controlled double-blind study.
    Cindoruk M; Erkan G; Karakan T; Dursun A; Unal S
    Helicobacter; 2007 Aug; 12(4):309-16. PubMed ID: 17669103
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Levofloxacin-containing triple therapy to eradicate the persistent H. pylori after a failed conventional triple therapy.
    Cheng HC; Chang WL; Chen WY; Yang HB; Wu JJ; Sheu BS
    Helicobacter; 2007 Aug; 12(4):359-63. PubMed ID: 17669110
    [TBL] [Abstract][Full Text] [Related]  

  • 40. DNA typing for Helicobacter pylori isolates from eradication-failed patients: comparison of the isolates before and after therapy.
    Nada T; Ando T; Nobata K; Tsuzuki T; Minami M; Ina K; Iinuma Y; Ichiyama S; Ohta M; El-Omar E; Kusugami K; Goto H
    Aliment Pharmacol Ther; 2004 Jul; 20 Suppl 1():39-47. PubMed ID: 15298604
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 31.